Heart Disease News and Research

Latest Heart Disease News and Research

New research on EKG signals could help heart patients in future

A physics major's passion for medicine led her into research that could help heart patients in the future.

16 Apr 2010

Albert Einstein College of Medicine of Yeshiva University receives funds to expand stem cell research capabilities

Albert Einstein College of Medicine of Yeshiva University has been awarded $10 million from the National Institutes of Health to expand its stem cell research capabilities. The funds will be used to create new laboratories in order to increase its already substantial base of stem cell investigators.

16 Apr 2010

Takeda Pharmaceutical offers milestone payment to XOMA

XOMA Ltd., a leader in the discovery and development of therapeutic antibodies, announced it has received a $1 million milestone payment from Takeda Pharmaceutical Company Limited for achieving a pre-established preclinical milestone under the companies' 2006 collaboration agreement, which also calls for additional future milestone payments and royalties on product sales.

16 Apr 2010

Lauric-acid-filled nano-scale bombs for treating acne

A natural product found in both coconut oil and human breast milk - lauric acid -- shines as a possible new acne treatment thanks to a bioengineering graduate student from the UC San Diego Jacobs School of Engineering. The student developed a "smart delivery system" - published in the journal ACS Nano in March - capable of delivering lauric-acid-filled nano-scale bombs directly to skin-dwelling bacteria (Propionibacterium acnes) that cause common acne.

15 Apr 2010

AVANIR Pharmaceuticals presents Phase III trial data of Zenvia for PBA at AAN Annual Meeting

AVANIR Pharmaceuticals, Inc. today announced the presentation of detailed data, including safety and tolerability data from the open-label extension as well as cardiac safety data from the double-blind phase of the Phase III confirmatory STAR trial evaluating the investigational drug Zenvia™ (dextromethorphan/quinidine) in the treatment of pseudobulbar affect (PBA). The data were presented in two posters at the American Academy of Neurology (AAN) Annual Meeting in Toronto, Canada.

15 Apr 2010

First Edition: April 15, 2010

In today's headlines: The jobless benefits package, including a COBRA subsidy extension and Medicare-doctor pay fix, advances in the Senate. In the House, a committee chairman cancels a hearing on business health care complaints.

15 Apr 2010

EU Joint Programming initiative to tackle neurodegenerative diseases

Leading researchers from across Europe will gather today in Stockholm to develop a European-wide research strategy to tackle neurodegenerative diseases such as Alzheimer's and Parkinson's Disease.

15 Apr 2010

Novel drug helps discover mechanisms underlying female sexual arousal

By using a novel prototype drug, researchers have discovered more about the mechanisms underlying female sexual arousal. These findings are published today in the British Journal of Pharmacology.

15 Apr 2010

Ibuprofen demonstrates efficacy over acetaminophen for treatment of pain and fever

Cumberland Pharmaceuticals Inc. today announced results from a meta-analysis comparing the efficacy and safety of ibuprofen and acetaminophen, which was published in the March edition of the peer-reviewed journal The Annals of Pharmacotherapy. The publication notes that in a majority of evaluated studies ibuprofen demonstrated superior efficacy compared to acetaminophen for the treatment of pain and fever, and found no significant safety differences between the drugs.

15 Apr 2010

Investment report on MIPI

StockPreacher.com announces an investment report featuring Molecular Insight Pharmaceuticals Inc.. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.

15 Apr 2010

MDA awards over $21M in grants for advancing critical neuromuscular research

Forty-two medical researchers and their labs have been awarded more than $21 million in grants by the Muscular Dystrophy Association to advance critical neuromuscular research in 2010. Many of the grants are multi-year awards to be dispersed over the next three years.

15 Apr 2010

Tobacco policies reduce exposure to secondhand smoke: The Cochrane Library

In countries and states that have introduced policies that restrict smoking in public, people have less exposure to secondhand smoke. There is also a reduction in the number of people who have heart attacks, as well as an improvement in other indicators of health. These findings are reported in a new review published in the April issue of The Cochrane Library.

15 Apr 2010

Genzyme presents 4-year follow-up data from Phase 2 MS trial at neurology meeting

Genzyme Corporation today reported four-year follow-up data from its completed Phase 2 multiple sclerosis (MS) trial showing an estimated 71 percent of alemtuzumab treated patients remain free of clinically-active disease as much as three years after most patients received their last course of the investigational compound. The data were presented at the American Academy of Neurology annual meeting.

15 Apr 2010

The nuts and bolts of reform's new policies

The New York Times: "In a new report, the Congressional Research Service says the law may have significant unintended consequences for the 'personal health insurance coverage' of senators, representatives and their staff members." Lawmakers agreed to depart from their existing health plans in order to join new health insurance exchanges, something they have made available to many of their constituents. But, while the exchanges don't start up until 2014, the law is silent on when lawmakers must ditch their current benefits.

15 Apr 2010

Bedtime video-games have no significant effect on adolescents’ sleep patterns

A study in the April 15 issue of the Journal of Clinical Sleep Medicine suggests that playing a video game before bedtime has only a mild effect on the sleep of older male teens.

15 Apr 2010

Artificial pancreas system succeeds in maintaining near-normal glucose levels

An artificial pancreas system that closely mimics the body's blood sugar control mechanism was able to maintain near-normal glucose levels without causing hypoglycemia in a small group of patients. The system, combining a blood glucose monitor and insulin pump technology with software that directs administration of insulin and the blood-sugar-raising hormone glucagon, was developed at Boston University.

15 Apr 2010

Patients with RLS using rotigotine achieve sustained improvements

New data presented at the 62nd American Academy of Neurology annual meeting in Toronto, Canada, showed that patients with moderate to severe Restless Legs Syndrome using rotigotine achieved sustained improvements in symptoms over 5 years of treatment.

15 Apr 2010

OrbusNeich Medical awarded US patent for "Stent with Helical Elements"

OrbusNeich Medical, Inc., a designer, developer, manufacturer and marketer of innovative medical devices for the treatment of cardiovascular diseases, today announced that on March 23, 2010, the Company was granted U.S. Patent No. 7,682,384 B2, entitled "Stent with Helical Elements." The patent relates to an expandable stent comprised of a plurality of helical segments. The Company noted that it has identified unlicensed use by Boston Scientific Corporation of certain technologies protected under U.S. Patent No. 7,682,384 B2.

15 Apr 2010

New cardiac CT technology promises low radiation exposure and improved image quality

Cardiovascular disease is the leading cause of death globally and a tremendous burden on the healthcare system. Better detection of hardening or clogging of arteries and other blood vessels before symptoms occur is needed.

15 Apr 2010

Study provides support for relationship between APOE4 gene and risk of Alzheimer's disease in Latinos

A brain-imaging study published today in the Archives of Neurology suggests that a major genetic risk factor for Alzheimer's disease in the Anglo population is also a risk factor for the disease in Latinos.

15 Apr 2010

Heart Disease News and Research

Latest Heart Disease News and Research

New research on EKG signals could help heart patients in future

Albert Einstein College of Medicine of Yeshiva University receives funds to expand stem cell research capabilities

Takeda Pharmaceutical offers milestone payment to XOMA

Lauric-acid-filled nano-scale bombs for treating acne

AVANIR Pharmaceuticals presents Phase III trial data of Zenvia for PBA at AAN Annual Meeting

First Edition: April 15, 2010

EU Joint Programming initiative to tackle neurodegenerative diseases

Novel drug helps discover mechanisms underlying female sexual arousal

Ibuprofen demonstrates efficacy over acetaminophen for treatment of pain and fever

Investment report on MIPI

MDA awards over $21M in grants for advancing critical neuromuscular research

Tobacco policies reduce exposure to secondhand smoke: The Cochrane Library

Genzyme presents 4-year follow-up data from Phase 2 MS trial at neurology meeting

The nuts and bolts of reform's new policies

Bedtime video-games have no significant effect on adolescents’ sleep patterns

Artificial pancreas system succeeds in maintaining near-normal glucose levels

Patients with RLS using rotigotine achieve sustained improvements

OrbusNeich Medical awarded US patent for "Stent with Helical Elements"

New cardiac CT technology promises low radiation exposure and improved image quality

Study provides support for relationship between APOE4 gene and risk of Alzheimer's disease in Latinos

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Heart Disease News and Research

Latest Heart Disease News and Research

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in